Business Description
ArcticZymes Technologies ASA
ISIN : NO0010014632
Compare
Compare
Traded in other countries / regions
AZT.NorwayB4V.Germany0DRV.UKBIOTECO.Sweden IPO Date
2012-10-01Description
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments, Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA followed by Lithuania, Germany, Italy, France, and other countries.
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 24.71 | |||||
Equity-to-Asset | 0.94 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | 0.42 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 31.38 | |||||
Beneish M-Score | -2.25 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.1 | |||||
3-Year EBITDA Growth Rate | -16.8 | |||||
3-Year EPS without NRI Growth Rate | -38.3 | |||||
3-Year FCF Growth Rate | -51.8 | |||||
3-Year Book Growth Rate | 14.8 | |||||
Future 3-5Y EPS without NRI Growth Rate | 56.22 | |||||
Future 3-5Y Total Revenue Growth Rate | 19.02 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 2 | |||||
9-Day RSI | 8.25 | |||||
14-Day RSI | 14.4 | |||||
6-1 Month Momentum % | -14.83 | |||||
12-1 Month Momentum % | -26.38 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 18.03 | |||||
Quick Ratio | 17.25 | |||||
Cash Ratio | 15.61 | |||||
Days Inventory | 705.94 | |||||
Days Sales Outstanding | 53.77 | |||||
Days Payable | 277.88 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.7 | |||||
Shareholder Yield % | 0.24 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 94.39 | |||||
Operating Margin % | 6.82 | |||||
Net Margin % | 12.6 | |||||
FCF Margin % | -0.12 | |||||
ROE % | 4.73 | |||||
ROA % | 4.34 | |||||
ROIC % | 6.22 | |||||
ROC (Joel Greenblatt) % | 29.37 | |||||
ROCE % | 5.5 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 75 | |||||
Forward PE Ratio | 46.56 | |||||
PE Ratio without NRI | 75 | |||||
Shiller PE Ratio | 133.65 | |||||
Price-to-Owner-Earnings | 677.42 | |||||
PS Ratio | 9.38 | |||||
PB Ratio | 3.38 | |||||
Price-to-Tangible-Book | 3.75 | |||||
Price-to-Free-Cash-Flow | 3000 | |||||
Price-to-Operating-Cash-Flow | 52.24 | |||||
EV-to-EBIT | 48.26 | |||||
EV-to-Forward-EBIT | 75.77 | |||||
EV-to-EBITDA | 35.72 | |||||
EV-to-Forward-EBITDA | 48.06 | |||||
EV-to-Revenue | 7.25 | |||||
EV-to-Forward-Revenue | 6.89 | |||||
EV-to-FCF | -6276.13 | |||||
Price-to-Projected-FCF | 2.37 | |||||
Price-to-Median-PS-Value | 0.79 | |||||
Price-to-Graham-Number | 3.53 | |||||
Price-to-Net-Current-Asset-Value | 4.17 | |||||
Price-to-Net-Cash | 4.88 | |||||
Earnings Yield (Greenblatt) % | 2.07 | |||||
FCF Yield % | -0.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ArcticZymes Technologies ASA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 116.047 | ||
EPS (TTM) (kr) | 0.28 | ||
Beta | -0.15 | ||
Volatility % | 38.43 | ||
14-Day RSI | 14.4 | ||
14-Day ATR (kr) | 0.418486 | ||
20-Day SMA (kr) | 23.9125 | ||
12-1 Month Momentum % | -26.38 | ||
52-Week Range (kr) | 20.2 - 36.55 | ||
Shares Outstanding (Mil) | 51.07 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
ArcticZymes Technologies ASA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
ArcticZymes Technologies ASA Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
ArcticZymes Technologies ASA Frequently Asked Questions
What is ArcticZymes Technologies ASA(OSTO:BIOTECO)'s stock price today?
The current price of OSTO:BIOTECO is kr20.95. The 52 week high of OSTO:BIOTECO is kr36.55 and 52 week low is kr20.20.
When is next earnings date of ArcticZymes Technologies ASA(OSTO:BIOTECO)?
The next earnings date of ArcticZymes Technologies ASA(OSTO:BIOTECO) is 2024-11-06.
Does ArcticZymes Technologies ASA(OSTO:BIOTECO) pay dividends? If so, how much?
ArcticZymes Technologies ASA(OSTO:BIOTECO) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |